Clinical Trials Browser

Phase 1/2 × Locally Advanced Cervical Carcinoma × sintilimab × Clear all

NCT06391190 2024-04-30

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

Phase 1/2 Recruiting

Locally Advanced Cervical Carcinoma